The cell surface low-density lipoprotein receptor-related protein 1, LRP1, plays a major role in lipid metabolism. The question that remains open concerns the function of LRP1 in adipogenesis. Here, we show that LRP1 is highly expressed in murine preadipocytes as well as in primary culture of human adipocytes. Moreover, LRP1 remains abundantly synthesised during mouse and human adipocyte differentiation. We demonstrate that LRP1 silencing in 3T3F442A murine preadipocytes significantly inhibits the expression of PPARc, HSL and aP2 adipocyte differentiation markers after adipogenesis induction, and leads to lipid-depleted cells. We further show that the absence of lipids in LRP1-silenced preadipocytes is not caused by lipolysis induction. In addition, we provide the first evidences that LRP1 is significantly up-regulated in obese C57BI6/J mouse adipocytes and obese human adipose tissues. Interestingly, silencing of LRP1 in fully-differentiated adipocytes also reduces cellular lipid level and is associated with an increase of basal lipolysis. However, the ability of mature adipocytes to induce lipolysis is independent of LRP1 expression. Altogether, our findings highlight the dual role of LRP1 in the control of adipogenesis and lipid homeostasis, and suggest that LRP1 may be an important therapeutic target in obesity.
Introduction
Consumption of meals rich in fat and carbohydrates is a major causative factor of obesity, resulting in excessive white adipose tissue. Adipose tissue serves as an energy reservoir and as an endocrine organ. An increase of adipose tissue mass results from combined hypertrophy of existing adipocytes (hypertrophic adipocytes) and adipogenic differentiation of precursor cells (hyperplasic adipocytes) [1] . Expression of the nuclear peroxisome proliferator-activated receptor c (PPARc) is known to be crucial for the initiation of adipocyte differentiation. Indeed, mice with a targeted adipocyte-specific deletion of the PPARc gene display a decreased adipose tissue mass [2] . Activation of PPARc induces the expression of lipogenic genes, such as adipocyte fatty acid binding protein (aP2), and of lipolytic genes, such as hormone-sensitive lipase (HSL) [3] . Interestingly, activated PPARc also stimulates the transcription of the low-density lipoprotein receptorrelated protein 1 (LRP1) in adipocytes [4] .
LRP1 is a 600-kDa multifunctional endocytic receptor that binds and internalizes a broad range of biologically diverse ligands including proteins important in lipoprotein metabolism [5] . LRP1 mediates the endocytotic internalization of dietary lipids carried in postprandial chylomicron remnants into hepatocytes by binding to Apolipoprotein E (ApoE) [6, 7] , particle-bound lipoprotein lipase (LpL) [8] and hepatic lipase [9] . Interestingly, LRP1 is expressed in adipocytes [4, 10, 11] and insulin stimulation of LRP1 increases the endocytic uptake of triglycerides and cholesteryl esters from remnant lipoproteins in postprandial adipocytes in a synergistic action with lipoprotein lipase [10] . Adipose-specific LRP1-knockout mice generated by crossing LRP1 flox/flox mice with aP2-Cre transgenic mice recently revealed its prominent role in lipid assimilation affecting energy metabolism and diet-induced obesity in mature adipocytes [12] . Even through the fundamental function of LRP1 in lipid homeostasis was recently revealed in mouse model [12] , its role in adipogenesis remains to be elucidated. Here, we report that LRP1 expression is necessary for adipocyte differentiation. Silencing of LRP1 in preadipocytes by the use of siRNAs significantly inhibits the expression of PPARc, HSL and aP2 adipocyte differentiation markers, and leads to lipid-depleted cells inept to induce lipolysis. Moreover, we corroborated the key function of LRP1 in maintaining the lipid levels in mature adipocytes. Until now, the implication of LRP1 in obesity has not been reported yet in human. Our study highlights, for the first time, that LRP1 expression is up-regulated in obese human tissue, and suggests that this receptor may be an interesting therapeutic target in obesity.
Results

LRP1 is highly expressed in adipocytes during adipogenesis in mouse and human
In order to explore the function of adipocytic LRP1, we first investigated the level of LRP1 protein expression in preadipocytes relative to fibroblasts and epithelial cancer cells. As illustrated in Figure 1A , LRP1 was abundantly expressed in preadipocytes (3T3-F442A, 3T3-L1) and in fibroblasts (NIH-3T3,   LRP1+/2 MEFs, HMF), when compared to epithelial mammary immortalized (HMT3522-S1) or cancer (MCF7, MDA-MB231) cells. As expected, no LRP1 expression was detected in LRP12/2 MEF cells (Fig. 1A) . To assess the role of LRP1 in preadipocytes, we next examined the regulation of its expression during the course of adipogenesis in the well-established murine 3T3F442A preadipocyte cell line, which has been validated as a valuable model of adipogenesis [13] ( Fig. 1B-C) . LRP1 mRNA (Fig. 1B) and LRP1b protein (Fig. 1C) were expressed at high levels along adipogenesis. Even through, a tendency of LRP1 up-regulation was observed, no statistical significance was reached (Fig. 1B-C) . To validate our experimental conditions, we studied in parallel the expression of PPARc (Fig. 1B) , HSL (Fig. 1C) and aP2 (Fig. 1B) adipocyte markers of differentiation. As attempted, the level of these markers was progressively increased during acquisition of the adipocyte phenotype (Fig. 1B-C) . In addition, the cytoskeletal bactin protein amount was diminished during adipocyte differentiation reflecting the change in cellular morphology (Fig. 1C) , as described before [14] .
Although 3T3F442A cells are a valuable experimental model, these preadipocytes have distinct attributes compared with human cells in primary culture beyond the obvious species differences. Therefore, we also analysed LRP1 expression during adipogenesis in human preadipocytes purified from abdominal subcutaneous adipose tissue using a recent approach [15] (Fig. 2) . These primary human cells were differentiated in an efficient manner since about 75% of preadipocytes were converted to the adipocyte phenotype ( Fig. 2A) and as reflected by HSL induction (Fig. 2B) . As observed for the mouse adipocyte, LRP1b protein remained abundantly expressed along human adipocyte differentiation (Fig. 2B) . Taken together, these findings report the presence of high LRP1 levels during adipocyte differentiation in both mouse and human.
Silencing of LRP1 expression inhibits adipogenesis
To determine whether preadipocyte requires LRP1 to differentiate into mature adipocyte, LRP1 expression was silenced in 3T3F442A preadipocytes using 3 LRP1 siRNAs. As shown in Figure 3A , a robust LRP1b extinction was observed two days posttransfection with LRP1 siRNAs as compared to control Luc siRNA. Consequently, we induced adipogenesis in control (Luc siRNA) and LRP1-silenced 3T3F442A preadipocytes two days post-transfection (Fig. 3B ). As shown in Fig. 3B , LRP1b protein expression was inhibited by the 3 LRP1 siRNAs as compared to Luc siRNA during differentiation. The most efficient siRNA, LRP1 siRNA1, inhibited LRP1b protein still after 7 days of differentiation (Fig. 3B) . A gradual lost of efficiency was observed with LRP1 siRNA2 and siRNA3 at days 3, 5 and 7 days of differentiation (Fig. 3B) . Similar LRP1 silencing was observed at the mRNA level (Fig. 4A, panel a;  Fig. 4B , panel a), with a significant reduction of 74% and 50% for LRP1 siRNA1 after 3 and 7 days of differentiation.
In order to evaluate the consequences of LRP1 silencing in adipocyte differentiation, we first quantified the expression of PPARc, HSL and aP2 adipocyte differentiation markers in Luc and LRP1 siRNA transfected 3T3F442A cells (Fig. 4) . LRP1 siRNA1 silencing (Fig. 4A , panel a) significantly inhibited PPARc (Fig. 4A , panel b), HSL (Fig. 4A , panel c) and aP2 (Fig. 4A, panel d ) mRNA levels at days 3 and 7 of differentiation. Extinction of LRP1 expression by LRP1 siRNA2 and siRNA3 (Fig. 4B , panel a) also reduced PPARc (Fig. 4B, panel b) , HSL (Fig. 4B , panel c) and aP2 (Fig. 4B, panel d ) mRNA levels at days 3 and 7 of differentiation but to a lesser extend as compared to LRP1 siRNA1. Hence, our results indicate that the gradual lost of LRP1 expression by LRP1 siRNAs (Fig. 4B, panel a) led to a concomitant decrease of adipocyte differentiation marker expression (Fig. 4B, panels b-d) . Altogether, these findings highlight that LRP1 tightly controls adipogenic expression markers in a dose-dependent manner. Then, we analysed the cellular lipid levels in adipocytes silenced or not for LRP1 (Fig. 5) . Indeed, the most obvious feature of adipocytes is the synthesis and storage of triglycerides in lipid droplets and therefore the gradual appearance and growth of lipid droplets are characteristic for adipocyte precursor cells undergoing adipogenic differentiation. The presence of these neutral lipids was detected by oil red O staining (Fig. 5A-B) . As illustrated in Fig. 5A , oil red O staining after 7 days of differentiation revealed that extinction of LRP1 expression by siRNA1 strongly decreased neutral lipid droplet formation and/or accumulation. Microscopic analysis at day 3 and 7 of differentiation illustrated that, as attempted, Luc siRNA-transfected 3T3F442A cells accumulated numerous large lipid droplets and adopted a non adherent round morphology characteristic of mature adipocytes (Fig. 5B , panels a and c). By contrast, in 3T3F442A cells silenced with LRP1 siRNA1, the lipid droplet size and number were strongly reduced (Fig. 5B , panels b and d). Moreover, cells kept the morphological feature of adherent fibroblastic cells, suggesting that preadipocyte differentiation process did not occur in the absence of LRP1. Quantification of lipids afterwards demonstrated that silencing of LRP1 with LRP1 siRNA1 significantly decreased lipid content levels by 7 fold at day 7 of differentiation ( Fig. 5C , panel a). LRP1 siRNA2 and siRNA3 also lowered the lipid content but to a lesser extend as compared to LRP1 siRNA1 (Fig. 5C, panel a) . Similar results were obtained by quantifying triglycerides (Fig. 5C , panel b). These results reveal that LRP1 silencing in preadipocytes inhibits adipogenesis, leading to lipid-depleted cells.
We finally studied the effects of silencing LRP1 in preadipocyte on lipolysis. Indeed, only mature adipocytes possess the complete apparatus for lipolysis. Our results indicating a significant decrease of HSL expression in LRP1 silenced cells (Fig. 4) , we, therefore, advocate that lipolysis should be absent in LRP1-silenced preadipocytes. An alternative could be that LRP1 silenced cells have an increased lipolysis, leading to lipid depleted cells. However, our results revealed that glycerol release over 18 h was significantly reduced in LRP1 silenced cells, indicating inhibition of basal lipolysis (Fig. 6A) . Moreover, glycerol and NEFA released in the media after isoproterenol treatment were also significantly decreased in LRP1 silenced cells, evidencing inhibition of induced-lipolysis. Therefore, extinction of LRP1 in preadipocytes abolishes expression of adipocyte differentiation markers and leads to lipid-depleted cells inept to induce lipolysis.
LRP1 expression is up-regulated in human and mouse obese adipose tissues
Obesity is characterized by the increase of intracellular lipid accumulation which shows a significant correlation with adipocyte differentiation. LRP1 mRNA expression was investigated in human intra-abdominal visceral adipose tissue (VAT) from lean (42.764. (Fig. 7) . Interestingly, LRP1 mRNA was significantly increased in human obese adipose tissue (Fig. 7A ). To assess whether this LRP1 up-regulation was a general characteristic of obese adipocytes, we then analysed LRP1 mRNA expression in adipocytes isolated from C57BI6/J mice either fed a HFD or ND (Fig. 7B) . As attempted HFD-fed C57BI6/J mice exhibited a significant increase in body mass (47.661.4 g) when compared to their control littermates (31.161.2 g) (data not shown). LRP1 expression was significantly enhanced in adipocytes of HFD obese mice when compared to ND control mice (Fig. 7B) . Altogether, our results indicate that LRP1 expression is upregulated in human and mouse obese adipose tissues.
Silencing of LRP1 expression inhibits the cellular lipid content of fully-differentiated adipocytes
Since we observed that LRP1 expression was up-regulated in obese adipose tissues, we finally investigated whether extinction of LRP1 expression in fully-differentiated adipocytes could diminish their lipid content (Fig. 8) , as recently suggested in adipose-specific LRP12/2 mouse model [12] . 3T3F442A preadipocytes were cultured for 10 days in adipogenic differentiation medium (Fig. 8A , panel a) and fully-differentiated adipocytes were transiently transfected with Luc siRNA or LRP1 siRNA1 (Fig. 8A, panel b) . Oil red O staining revealed that, after 7 days of culture, the lipid droplet size and number were decreased in LRP1 siRNA1 transfected adipocytes (Fig. 8B-C) . Quantification of lipids at days 2 and 7 of culture revealed that, in Luc siRNA transfected adipocytes, the level of cellular lipid remained unchanged whereas, in LRP1 siRNA1 transfected cells, the amount of lipid was significantly diminished by 27.8% (Fig. 8D) . Interestingly, basal lipolysis was significantly stimulated in LRP1 siRNA1 transfected adipocytes (Fig. 9, panel a) . We postulate that, since cells could not internalized triglycerides in the absence of LRP1 as previously shown [12] , they were metabolizing their intracellular lipid stock. However, induced lipolysis was not different in LRP1 and Luc siRNA transfected cells (Fig. 9, panel b) . Altogether, these findings highlight, for the first time, the crucial role of LRP1 in controlling adipogenesis and maintaining the lipid content in fully-differen- tiated adipocytes, and suggest that LRP1 may be an important therapeutic target in obesity.
Discussion
Here, we show that LRP1 is highly expressed in 3T3F442A murine preadipocyte cell line, as previously described for 3T3L1 preadipocytes and embryonic fibroblasts [16, 17] . Since LRP1 is expressed at high levels in preadipocytes, it therefore can be involved in the early steps of adipocyte differentiation. Indeed, our report demonstrate that LRP1 silencing by siRNAs in 3T3F442A preadipocytes significantly inhibits the expression of PPARc, HSL and aP2 adipocyte markers of differentiation and leads to lipiddepleted cells, indicating that LRP1 is a key regulator of the adipogenic process. Our experiments using 3 LRP1 siRNAs show that LRP1 extinction abrogates adipocyte differentiation in a LRP1 dose-dependent manner. Our results also pinpoint that extinction of LRP1 expression in pre-adipocytes prevents their lipolytic response both at a basal level and after isoproterenol induction. Therefore the inhibition of lipid accumulation and triglyceride levels observed in LRP1-silenced preadipocytes is not the consequence of a stimulation of lipolysis, indicating a direct effect of LRP1 on the control of the adipogenic process. PPARc is known to be crucial for the initiation of adipocyte differention [2] . Interestingly, PPARc has been described to induce LRP1 transcription [4] and our results indicate that LRP1 silencing inhibits PPARc expression. This suggests the existence of a regulatory loop between these two factors. Our findings reveal that LRP1 silencing inhibits the expression of PPARc by 80% at day 3 of differentiation, indicating an early effect of LRP1 at the commencement of adipogenesis. It is therefore important to determine how LRP1 lost down-regulates PPARc expression. A recent study demonstrates that LRP1 controls gene transcription via Regulated Intramembrane Proteolysis through the cytoplasmic release of LRP1 intracellular domain, LRP1-ICD [18] . Studies in the future will investigate whether LRP1-ICD regulates PPARc expression in preadipocytes.
Our results also indicate, for the first time, that LRP1 expression is up-regulated in human obese tissue. This up-regulation of LRP1 expression in the VAT of overweight/obese patients is in consensus with our results in obese mice. Obesity is characterized by the increase of intracellular lipid accumulation which shows a significant correlation with adipocyte differentiation. Terminally differentiated adipocytes cannot divide. Hence, alterations in the number of fat cells within the body must be accomplished by the differentiation of preadipocytes, which act as a renewable source of adipocytes. Interestingly, our in vitro study in 3T3F442A cells indicates that LRP1 expression is required for adipocyte differentiation and since LRP1 is abundantly expressed in adipocytes, we propose that LRP1 may participate in the onset of obesity. The crucial role of LRP1 in obesity is also supported by a recent study showing that adipocyte LRP12/2 mice have an overall decrease in fat mass and are protected from high-fat dietinduced obesity [12] . Our experiments further show that silencing of LRP1 in fully-differentiated adipocytes significantly reduces cellular lipid content, suggesting that LRP1 may be an important therapeutic target in obesity. Most functional studies on adipocyte differentiation and function have been performed in the murine adipogenic 3T3L1 cell line and in genetically modified mice. However, there are fundamental differences in the lipoprotein metabolism of mouse and human [19] . Therefore, it is important to investigate the LRP1 expression in human adipocytes as presented in this report.
Results from the literature have suggested that LRP1 is a likely contributor to adipogenesis, adipocyte homeostasis and obesity given its high expression in adipocytes [4, 10, 11] , that it binds ApoE [7, 8] , LpL [20, 21] and hepatic lipase [9] , and that it collaborates with heparin sulfate proteoglycans to mediate the internalization of ApoE and LpL [22, 23] . The dietary lipids are carried in chylomicron remnants (CR) which are taken up into the liver mainly via LRP1. LRP1 interacts with CR via ApoE [6, 7] and LpL in vitro and in vivo [8, 24] . Interestingly, ApoE has been reported to be crucial for the accumulation of triglycerides in mouse adipocytes [25] and also appears to have an important function in adipocyte differentiation [26] and obesity [27] . Altogether, these observations strongly suggest that a deregulation of LRP1 expression may have important consequences in adipocytes and obesity.
Some insight into LRP1 function in mature adipocyte was obtained by generating mice with adipocyte-specific inactivation of the LRP1 gene [12] . Adipocyte LRP1 knockout mice displayed delayed postprandial lipid clearance, smaller fat stores, and lipiddepleted adipocytes which resulted in reduced body weight due to overall decrease in fat mass. This work highlights the importance of adipocyte LRP1 in postprandial triglyceride metabolism, where LRP1 in collaboration with LpL mediates both the endocytic and lipolytic processes responsible for triglyceride catabolism [23, 28, 29] . Our results are in accordance with this study and indicate that extinction of LRP1 expression in mature adipocytes leads to increased basal lipolysis. In addition, we show that the capacity of mature adipocytes to induce lipolysis in response to isoproterenol is not modified by LRP1 silencing. This suggests that LRP1 does not directly control lipolysis. We propose that inhibition of LRP1 expression stimulates basal lipolysis in order to compensate the lack of lipid intake in the absence of LRP1. Recently, it was shown that LRP1 is also required for lipolysis and the control of intracellular cholesterol storage and fatty acid synthesis via the Wnt5a signaling pathway in LRP12/2 MEF cells [30] .
In conclusion, our findings highlight that LRP1 plays a crucial role in the control of adipogenesis and lipid homeostasis in mature adipocytes. Moreover, our results indicate that LRP1 is upregulated in human obese tissues and mouse adipocytes. Therefore, we propose that LRP1 targeting in obesity may lead to a reduction of hypertrophic and hyperplasic adipocytes.
Materials and Methods
Ethics Statement
All subjects gave their informed written consent to participate to the study, and investigations were performed in accordance with the declaration of Helsinki as revised in 2000 (http://www.wma. net/e/policy/b3.htm).
Cells and cell culture
Cell lines were cultured in DMEM (Invitrogen) supplemented with 10% fetal calf serum (FCS). Differentiation was induced by incubating 3T3F442A confluent cells in differentiation medium (DMEM supplemented with 10% FCS and 50 nM insulin) as described previously for up to 7 days [31] . After 7 days of differentiation, cells were maintained in DMEM with 10% FCS.
Human samples
Human adipose tissue was collected according to the guidelines of the Ethical Committee of Toulouse-Rangueil and Nancy J. 2 ) before a bariatric surgery. All subjects were drug-free and besides obesity they did not suffer of any disease. Tissue samples were immediately frozen in liquid nitrogen and stored at 280uC. Total RNAs of isolated adipocytes were extracted and LRP1 expression analysed by RT-PCR. For in vitro differentiation, human preadipocytes were isolated from human subcutaneous adipose tissue obtained from patients undergoing abdominal lipectomy at the plastic surgery department of Rangueil Hospital (Toulouse, France) under the agreement of local ethic committee. All subjects gave their informed written consent to participate to the study. Adipose tissue pieces were immediately used for collagenase digestion as previously described [15] . The digestate was centrifuged to separate adipocytes from the stroma-vascular fraction, containing preadipocytes (pellet). Cells isolated from the SVF fraction were induced to differentiate into adipocytes as previously described [31] . Briefly, confluent cells (day 0) were induced to differentiate in DMEM/Ham's F12 (1:1) medium containing 0.01 mg/ml transferrin, 100 nM cortisol, 0.2 nM triiodothyronine, and 20 nM insulin. To trigger differentiation, 25 nM dexamethasone, 500 mM IBMX and 2 mM rosiglitazone were present from day 0 to day 4. Intracellular accumulation of lipid droplets became clearly evident at day 10 [15] .
Mice
Mice were handled in accordance with the principles and guidelines established by the National Institute of Medical Research (INSERM). C57Bl6/J female mice were obtained from Charles River laboratory (l'Arbresle, France). Mice were housed conventionally in a constant temperature (20-22uC) and humidity (50-60%) animal room and with a 12 h light-dark cycle. All mice had free access to food and water throughout the experiment. C57Bl6/J mice were assigned to normal-fat diet (ND) or high-fat diet (HFD) (SAFE, France). Energy contents of the specific diets were (% kcals): 20% protein, 70% carbohydrate, and 10% fat for ND; 20% protein, 35% carbohydrate, and 45% fat for HFD. The main source of fat in HFD was lard (20 g/100 g of food). C57Bl6/ J (10 week old) mice were fed a ND or HFD for 20 weeks. All mice were sacrificed at 30 weeks of age.
Isolation of adipocytes from mouse adipose tissue
Mouse intra-abdominal adipose tissues were dissected immediately after sacrifice, minced in 5 ml of Dulbecco's modified Eagle's medium (DMEM; Life Technologies, Inc., Invitrogen, Paisley, UK) supplemented with 1 mg/ml collagenase (SIGMA) and 1% BSA for 30 min at 37uC under shaking. Digestion was followed by filtration through a 150 mm screen, and the floating adipocytes were separated from the medium containing the stroma-vascular fraction (SVF). Adipocytes were washed twice in DMEM and further processed for RNA extraction using the RNeasy mini kit (Qiagen, Germany).
Immunoblots
Cells were lysed in lysis buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1% Triton X100, 1.5 mM MgCl 2 , 1 mM EGTA, 100 mM NaF, 10 mM NaPPI, 500 mm NaVanadate, 1 mM PMSF, 10 mM Aprotinine, and a protease inhibitor cocktail). After gentle shaking for 20 min at 4uC, cell extracts were obtained by centrifugation in a microfuge at 13,000 rpm for 15 min at 4uC. Equal amounts of protein (100 mg) from cell extracts, quantitated by the Bradford assay, were separated on a 7% gel by SDS-PAGE. Proteins were electrotransferred to PVDF membrane and incubated with 1 mg/ml antia tubulin (NeoMarkers), 1 mg/ml anti-b2actin (Sigma), 1 mg/ml ERK2 (D-2, Santa Cruz Biotechnology), 11H4 anti-LRP1b hybridoma (1/10 dilution, ATCC) or 0.4 mg/ml anti-HSL (Santa Cruz). Proteins were then visualized with horseradish peroxidaseconjugated sheep anti-mouse immunoglobulin (ECL Amersham) or horseradish peroxidase-conjugated donkey anti-rabbit immunoglobulin (ECL Amersham) followed by the Renaissance chemiluminescence system (Perkin Life Sciences).
RNA extraction and analysis
Total RNA was extracted using the RNeasy minikit (QIAGEN Sciences, Maryland) according to the manufacturer's instructions. Reverse transcription of total RNA was performed at 37uC using Moloney murine leukemia virus reverse transcriptase enzyme (Invitrogen, Carlsbad, CA) and random hexanucleotide primers (Promega, Madison, WI). Quantitative PCR was carried out by real-time PCR using a LightCycler and the DNA double-strandspecific SYBR green I dye for detection (Roche, Basel, Switzerland). Results were normalized to RS9 levels. Sequences of primers are: mouse RS9 (sens 59CGGCCCGGGAGCTGTTGACG39, reverse 59CTGCTTGCGGACCCTAATGTGACG39), mouse aP2 (sens 59AACACCGAGATTTCCTTCAA39, reverse 59AGTCACGCCTTTCATAACACA39), mouse LRP1 (sens 59GACCAGGTGTTGGACACAGATG39, reverse 59AGTCGTTGTCTCCGTCACACTTC39), mouse HSL (sens 59CTGAAGGCTCTGAGTTGGTCAA39, reverse 59GGCTTACTGGGCACAGATACCT39), mouse PPARc (sens 59 AGGCCGAGAAGGAGAAGCTG-TTG39, reverse 59TGGCCACCTCTTTGCTCTGCTC39), human LRP1 (sens 59TAGACCGGCCCCCTGTGCTGTTG-A39, reverse 59GGTCTGCCGCGTGCTCGTAGGTGT39).
siRNAs and 3T3F442A transfection
Silencing of LRP1 gene expression in adipocytes was achieved by the use of siRNAs. Duplexes of 21-nucleotide mouse LRP1 siRNA1 (target sequence AAGCATCTCAGTAGACTATCA) [32] , mouse LRP1 siRNA2 (target sequence AACTTCTTAAACTCATAGCTT) (Dharmacon), mouse LRP1 siRNA3 (target sequence AAG-CAGTTTGCCTGCAGAGAC) or firefly luciferase (Luc) siRNA (target sequence AACGTACGCGGAATACTTCGA) were synthesized by MWG Biotech S.A. (France). 2 10 6 3T3F442A mature adipocytes were transiently transfected with 2 mg of siRNA using Nucleofector Technology (Amaxa biosystems) according to the manufacturer's instructions using kit L (# VCA-1005) and were replated in 2 wells of 6-well plates. After 48 h of transfection, cells have recovered and were maintained in DEM 10% FCS for further analysis. Analysis of LDH release monitored at 48 h revealed no toxicity of transfecting mature adipocytes with LRP1 or Luc siRNAs (CytoTox96 Non-Radioactive Cytotoxicity Assay, Promega). For preadipocytes, 10 6 cells were transfected and were treated with insulin 48 h posttransfection.
Oil Red O staining
3T3F442A adipocytes were washed with phosphate-buffered saline (pH 7.4) and then fixed with Antigenfix (Diapath, Italy). Cells were stained with Oil Red O dye (saturated Oil Red O dye in six parts of isopropanol and four parts of water), an indicator of cell lipid content, and then exhaustively rinsed with water. Spectrophotometric quantification of lipids was performed by dissolving the stained oil droplets with isopropanol and measuring absorbance at 540 nm as previously described [33] .
Quantification of triglycerides
Cells scraped in PBS were centrifugated for 5 min at 1200 rpm at 4uC. Cell pellet was dissolved in 40 ml isopropanol and centrifugated at 13 000 rpm for 5 min at 4uC. The supernatant was used to determine the triglyceride content using the Triglyceride FS kit (Diasys Diagnostic Systems, Germany) according to the manufacturer's instructions. The pellet was used to quantify DNA concentration by a diaminobenzoic aci fluorescence assay [34] .
Lipolysis Assay
Cells were incubated in DMEM without serum in the presence of 2% fatty acid-free bovine serum albumin (A7030, Sigma) overnight. Fresh medium containing isoproterenol was added for 90 min. Glycerol and NEFA contents in the medium were measured with free glycerol reagent (F6428 Sigma) and NEFA C kit (Wako Chemicals, Germany).
Statistical analysis
Results are expressed as means 6 SEM. Statistical differences between two groups were evaluated using Student's t tests. The level of significance was set at P,0.05.
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